The effect of ligand lipophilicity on the nanoparticle encapsulation of Pt(IV) prodrugs (Q37171242)

18 August 2017

The effect of ligand lipophilicity on the nanoparticle encapsulation of Pt(IV) prodrugs (English)

1 reference

18 August 2017

0 references

2

Stephen J Lippard

1 reference

18 August 2017

Timothy C Johnstone

1

1 reference

PMC publication ID

3773226

18 August 2017

language of work or name

English

0 references

publication date

16 July 2013

1 reference

18 August 2017

1 reference

18 August 2017

52

1 reference

18 August 2017

17

1 reference

18 August 2017

9915-9920

1 reference

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

The status of platinum anticancer drugs in the clinic and in clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Impact of nanotechnology on drug delivery.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

The resurgence of platinum-based cancer chemotherapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Platinum Compounds: a New Class of Potent Antitumour Agents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2].

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure–activity relationship modeling

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773226

Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23859129

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23859129

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23859129

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1021/IC4010642

1 reference

18 August 2017

1 reference

PMC publication ID

3773226

18 August 2017

PubMed publication ID

23859129

1 reference

PMC publication ID

3773226